V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180012614 | 180003673 | null | null | null | null | 2019-11-16 | Temozolomide 150mg/m2 | null | null | CAPECITABINE + OXALIPLATIN | 101753834 |
| 180012640 | 180003674 | null | null | null | null | 2021-09-27 | Sorafenib | null | null | AFATINIB | 101299721 |
| 180012978 | 180003680 | null | null | null | null | 2018-12-03 | null | 2 | null | DOXORUBICIN | 101626024 |
| 180013089 | 180003681 | null | null | null | 2018-12-30 | 2019-04-08 | STS Rhabdo RMS 2005 2nd Topo Cyclo | null | null | VENETOCLAX | 100101985 |
| 180013095 | 180003682 | 0 | null | null | null | 2019-06-24 | CISPLATIN + DOXORUBICIN + ETOPOSIDE | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 101518971 |
| 180013322 | 180003686 | 0 | null | null | null | 2018-09-29 | CABOZANTINIB | null | null | VANDETANIB | 100503947 |
| 180013380 | 180003688 | null | null | null | null | 2019-07-29 | CETUXIMAB + IRINOTECAN + MDG | null | null | NB RELAPSE TEMOZOLOMIDE/ TOPOTECAN | 101206781 |
| 180000404 | 180003692 | null | null | null | 2021-05-20 | 2021-06-10 | Etoposide oral | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100480276 |
| 180003586 | 180003698 | null | null | null | null | 2019-12-05 | Mitotane 3 - 3.5g | null | null | GEMCITABINE | 100173608 |
| 180003957 | 180003699 | null | null | null | null | 2017-12-28 | CNS GCT II Germinoma - Ifos Etop | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 100145390 |
| 180004053 | 180003700 | null | null | null | null | 2021-12-28 | ETOPOSIDE | null | null | LETROZOLE + PALBOCICLIB | 101226306 |
| 180007207 | 180003705 | null | null | null | 2019-05-04 | 2020-06-28 | Trial Unspecified | null | null | NOT MATCHED | 100314802 |
| 180009008 | 180003707 | null | null | null | null | 2020-11-25 | Carboplatin + Paclitaxel (3 weekly) | null | null | NB HRNBL-1 COJEC IND COURSE A | 101188516 |
| 180010000 | 180003710 | null | null | null | 2019-08-19 | 2019-08-26 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | null | null | EVEROLIMUS | 101820973 |
| 180011492 | 180003713 | 0 | null | null | 2019-07-15 | 2020-04-06 | null | null | null | CARBOPLATIN | 100803658 |
| 180000263 | 180003726 | null | null | null | null | 2022-01-04 | Cyclophosphamide + Vincristine | null | null | MITOTANE | 100467945 |
| 180001855 | 180003747 | null | null | null | 2021-03-12 | 2021-04-01 | CNS GCT II Germinoma - Ifos Etop | null | null | TRIAL UNSPECIFIED | 100849373 |
| 180002031 | 180003749 | null | null | null | null | 2019-11-22 | NB HRNBL-1 BUMEL MAT | null | null | PEMETREXED | 101142828 |
| 180002317 | 180003750 | null | null | null | 2021-08-01 | 2021-08-05 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 101698111 |
| 180002916 | 180003753 | null | null | null | null | 2017-10-10 | NB HRNBL-1 BUMEL MAT | null | null | LENVATINIB | 101686218 |
| 180002997 | 180003754 | null | null | null | 2017-07-31 | 2017-08-16 | Cyclophosphamide + Topotecan | null | null | NB HRNBL-1 CH14.18/CHO(TRIAL) +IL-2 | 101279895 |
| 180003140 | 180003757 | null | null | null | null | 2021-08-12 | null | null | null | LENVATINIB | 100305855 |
| 180003233 | 180003759 | null | null | null | null | 2019-11-26 | NB HRNBL-1 Isotretinoin | null | null | NB HRNBL-1 ISOTRETINOIN | 100041444 |
| 180003267 | 180003760 | null | null | null | null | 2017-08-01 | NB HRNBL-1 Isotretinoin | null | null | LENVATINIB | 100452690 |
| 180003423 | 180003764 | null | null | null | 2022-02-21 | 2022-02-26 | NB HRNBL | null | null | LENVATINIB | 100328266 |
| 180003574 | 180003767 | 1.81 | null | null | null | 2018-08-12 | Dinutuximab Beta | null | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 101706487 |
| 180003626 | 180003771 | null | null | null | null | 2018-01-28 | Mitotane 5.5 - 10g | null | null | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 101401458 |
| 180003829 | 180003775 | null | null | null | 2019-12-15 | 2019-12-18 | NB HRNBL-1 BUMEL MAT | 02 | null | PEMBROLIZUMAB | 101850933 |
| 180003913 | 180003777 | null | null | null | null | 2021-04-23 | Trial Unspecified | null | null | FLUOROURACIL + IRINOTECAN | 100923552 |
| 180003921 | 180003778 | null | null | null | null | 2019-06-24 | NB BEACON Temozolomide Topotecan | null | null | TRIAL UNSPECIFIED | 100667986 |
| 180004003 | 180003782 | null | null | null | null | 2020-05-18 | Letrozole + Palbociclib | null | null | TRIAL UNSPECIFIED | 101639241 |
| 180004246 | 180003786 | null | null | null | null | 2016-09-07 | CYCLO + DOXORUBICIN + VINCRISTINE | null | null | DOCETAXEL | 101391037 |
| 180004325 | 180003788 | null | null | null | null | 2020-06-24 | Cetuximab 7 day (>Cycle 2) | null | null | CISPLATIN + DOXORUBICIN | 100248806 |
| 180004541 | 180003792 | null | null | null | 2018-12-27 | 2020-01-17 | null | null | null | TEMOZOLOMIDE | 100403978 |
| 180004587 | 180003793 | null | null | null | null | 2019-10-22 | Temozolomide 150mg/m2 | null | null | DOCETAXEL | 100848422 |
| 180004626 | 180003795 | null | null | null | null | 2016-07-04 | Oxaliplatin + Modified de Gramont | null | null | CARBOPLATIN + GEMCITABINE + RITUXIMAB | 101486943 |
| 180004847 | 180003799 | null | null | null | null | 2020-08-24 | NB HRNBL | null | null | NB HRNBL-1 CH14.18/CHO(TRIAL) +IL-2 | 101273900 |
| 180004943 | 180003801 | null | null | null | 2018-09-29 | 2018-10-04 | CAPECITABINE + GEMCITABINE | null | null | FLUOROURACIL + OXALIPLATIN | 100113751 |
| 180005092 | 180003803 | null | null | null | null | 2022-02-10 | DABRAFENIB + TRAMETINIB | null | null | NB HRNBL-1 ISOTRETINOIN | 100972126 |
| 180005369 | 180003807 | null | null | null | null | 2016-12-22 | TEMOZOLOMIDE | null | null | PACLITAXEL | 101475349 |
| 180005790 | 180003815 | null | null | null | null | 2018-09-06 | GEMCITABINE + NAB PACLITAXEL | null | null | IRINOTECAN + TEMOZOLOMIDE | 101587585 |
| 180006008 | 180003820 | null | null | null | null | 2018-05-21 | LANREOTIDE | null | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 101712023 |
| 180006136 | 180003823 | null | null | null | 2019-01-27 | 2019-02-06 | FLUOROURACIL | null | null | NB HRNBL-1 ISOTRETINOIN | 100012883 |
| 180006180 | 180003824 | 0 | null | null | 2017-12-10 | 2018-01-28 | Temozolomide 200mg/m2 | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 101423045 |
| 180006580 | 180003832 | null | null | null | 2017-05-19 | 2018-02-25 | EVEROLIMUS + EXEMESTANE | null | null | RITUXIMAB | 100809680 |
| 180006703 | 180003834 | null | null | null | null | 2017-09-20 | LENVATINIB | null | null | RUXOLITINIB | 101684845 |
| 180006830 | 180003836 | null | null | null | null | 2017-11-10 | ABEMACICLIB + FULVESTRANT | null | null | NIVOLUMAB | 101821960 |
| 180006912 | 180003837 | 1.78 | null | null | 2019-11-23 | 2020-06-19 | null | null | null | LENVATINIB | 101745337 |
| 180007019 | 180003838 | null | null | null | null | 2016-05-02 | null | null | null | LENVATINIB | 100527095 |
| 180007034 | 180003839 | null | null | null | 2019-10-08 | 2020-11-28 | CNS GCT II Germinoma - Ifos Etop | null | null | LENVATINIB | 101678730 |